Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 16913 | 24.49 |
09:34 ET | 2578 | 24.6672 |
09:36 ET | 2755 | 24.645 |
09:38 ET | 3650 | 24.67 |
09:39 ET | 2491 | 24.62 |
09:41 ET | 4459 | 24.61 |
09:43 ET | 3600 | 24.655 |
09:45 ET | 3370 | 24.66 |
09:48 ET | 4200 | 24.655 |
09:50 ET | 1893 | 24.66 |
09:52 ET | 5832 | 24.65 |
09:54 ET | 14763 | 24.71 |
09:56 ET | 5687 | 24.74 |
09:57 ET | 3441 | 24.71 |
09:59 ET | 26546 | 24.74 |
10:01 ET | 2056 | 24.66 |
10:03 ET | 1026 | 24.67 |
10:06 ET | 4061 | 24.71 |
10:08 ET | 4175 | 24.72 |
10:10 ET | 2413 | 24.71 |
10:12 ET | 2067 | 24.74 |
10:14 ET | 2245 | 24.72 |
10:15 ET | 4447 | 24.735 |
10:17 ET | 900 | 24.74 |
10:19 ET | 3792 | 24.73 |
10:21 ET | 5079 | 24.73 |
10:24 ET | 1713 | 24.725 |
10:26 ET | 1110 | 24.7399 |
10:28 ET | 400 | 24.735 |
10:30 ET | 3709 | 24.72 |
10:32 ET | 4020 | 24.74 |
10:33 ET | 350 | 24.74 |
10:35 ET | 4949 | 24.72 |
10:37 ET | 700 | 24.725 |
10:39 ET | 4297 | 24.74 |
10:42 ET | 3055 | 24.75 |
10:44 ET | 11552 | 24.8 |
10:46 ET | 3421 | 24.79 |
10:48 ET | 5344 | 24.73 |
10:50 ET | 2000 | 24.76 |
10:51 ET | 5800 | 24.76 |
10:53 ET | 2232 | 24.75 |
10:55 ET | 7224 | 24.77 |
10:57 ET | 1438 | 24.77 |
11:00 ET | 1937 | 24.76 |
11:02 ET | 1262 | 24.735 |
11:04 ET | 2324 | 24.735 |
11:06 ET | 2082 | 24.735 |
11:08 ET | 3781 | 24.725 |
11:09 ET | 800 | 24.725 |
11:11 ET | 3582 | 24.7 |
11:13 ET | 385 | 24.7 |
11:15 ET | 2283 | 24.645 |
11:18 ET | 5368 | 24.64 |
11:20 ET | 492 | 24.635 |
11:22 ET | 2063 | 24.62 |
11:24 ET | 750 | 24.585 |
11:26 ET | 1705 | 24.585 |
11:27 ET | 5229 | 24.59 |
11:29 ET | 331 | 24.58 |
11:31 ET | 1965 | 24.54 |
11:33 ET | 4732 | 24.55 |
11:36 ET | 301 | 24.55 |
11:38 ET | 2865 | 24.54 |
11:40 ET | 2444 | 24.49 |
11:42 ET | 2431 | 24.48 |
11:44 ET | 5664 | 24.52 |
11:45 ET | 3108 | 24.51 |
11:47 ET | 409 | 24.505 |
11:49 ET | 2933 | 24.48 |
11:51 ET | 7710 | 24.46 |
11:54 ET | 1400 | 24.455 |
11:56 ET | 2867 | 24.435 |
11:58 ET | 4470 | 24.44 |
12:00 ET | 1048 | 24.435 |
12:02 ET | 1300 | 24.425 |
12:03 ET | 1459 | 24.425 |
12:05 ET | 1727 | 24.405 |
12:07 ET | 5177 | 24.42 |
12:09 ET | 3272 | 24.455 |
12:12 ET | 20633 | 24.46 |
12:14 ET | 100 | 24.47 |
12:16 ET | 7394 | 24.45 |
12:18 ET | 2206 | 24.44 |
12:20 ET | 18222 | 24.49 |
12:21 ET | 34105 | 24.47 |
12:23 ET | 900 | 24.47 |
12:25 ET | 7623 | 24.475 |
12:27 ET | 2416 | 24.47 |
12:30 ET | 1037 | 24.46 |
12:32 ET | 2990 | 24.465 |
12:34 ET | 1308 | 24.465 |
12:36 ET | 6522 | 24.445 |
12:38 ET | 1576 | 24.42 |
12:39 ET | 535 | 24.42 |
12:41 ET | 3121 | 24.45 |
12:43 ET | 1000 | 24.48 |
12:45 ET | 5723 | 24.48 |
12:48 ET | 839 | 24.485 |
12:50 ET | 1906 | 24.47 |
12:52 ET | 93303 | 24.44 |
12:54 ET | 3802 | 24.5 |
12:56 ET | 1941 | 24.51 |
12:57 ET | 3400 | 24.49 |
12:59 ET | 600 | 24.49 |
01:01 ET | 2765 | 24.56 |
01:03 ET | 1219 | 24.5602 |
01:06 ET | 4403 | 24.61 |
01:08 ET | 1858 | 24.55 |
01:10 ET | 237 | 24.57 |
01:12 ET | 1317 | 24.58 |
01:14 ET | 1212 | 24.575 |
01:15 ET | 1600 | 24.59 |
01:17 ET | 2792 | 24.59 |
01:19 ET | 237 | 24.58 |
01:21 ET | 2065 | 24.57 |
01:24 ET | 2668 | 24.53 |
01:26 ET | 3567 | 24.52 |
01:28 ET | 700 | 24.525 |
01:30 ET | 5266 | 24.5 |
01:32 ET | 200 | 24.505 |
01:33 ET | 2474 | 24.515 |
01:35 ET | 341 | 24.515 |
01:37 ET | 2449 | 24.505 |
01:39 ET | 26833 | 24.5 |
01:42 ET | 3703 | 24.48 |
01:44 ET | 100 | 24.49 |
01:46 ET | 2365 | 24.46 |
01:48 ET | 500 | 24.465 |
01:50 ET | 1986 | 24.475 |
01:51 ET | 5729 | 24.465 |
01:53 ET | 100 | 24.465 |
01:55 ET | 2764 | 24.44 |
01:57 ET | 2300 | 24.41 |
02:00 ET | 1489 | 24.41 |
02:02 ET | 3654 | 24.36 |
02:04 ET | 3194 | 24.33 |
02:06 ET | 4552 | 24.35 |
02:08 ET | 1555 | 24.34 |
02:09 ET | 3845 | 24.34 |
02:11 ET | 973 | 24.32 |
02:13 ET | 854 | 24.325 |
02:15 ET | 5762 | 24.285 |
02:18 ET | 1743 | 24.275 |
02:20 ET | 2157 | 24.295 |
02:22 ET | 5622 | 24.26 |
02:24 ET | 1462 | 24.26 |
02:26 ET | 2019 | 24.265 |
02:27 ET | 2923 | 24.25 |
02:29 ET | 5613 | 24.21 |
02:31 ET | 3175 | 24.21 |
02:33 ET | 3200 | 24.225 |
02:36 ET | 2257 | 24.22 |
02:38 ET | 6050 | 24.19 |
02:40 ET | 5162 | 24.195 |
02:42 ET | 2589 | 24.22 |
02:44 ET | 1135 | 24.22 |
02:45 ET | 1694 | 24.21 |
02:47 ET | 3900 | 24.24 |
02:49 ET | 4448 | 24.23 |
02:51 ET | 17374 | 24.205 |
02:54 ET | 3931 | 24.215 |
02:56 ET | 17586 | 24.255 |
02:58 ET | 5434 | 24.235 |
03:00 ET | 1680 | 24.245 |
03:02 ET | 2926 | 24.275 |
03:03 ET | 5353 | 24.265 |
03:05 ET | 600 | 24.26 |
03:07 ET | 600 | 24.265 |
03:09 ET | 2067 | 24.265 |
03:12 ET | 1901 | 24.265 |
03:14 ET | 7165 | 24.225 |
03:16 ET | 607 | 24.215 |
03:18 ET | 6354 | 24.231 |
03:20 ET | 8686 | 24.16 |
03:21 ET | 2811 | 24.2 |
03:23 ET | 4036 | 24.192 |
03:25 ET | 789 | 24.195 |
03:27 ET | 4099 | 24.18 |
03:30 ET | 9270 | 24.2 |
03:32 ET | 2412 | 24.185 |
03:34 ET | 33162 | 24.185 |
03:36 ET | 41810 | 24.175 |
03:38 ET | 3610 | 24.18 |
03:39 ET | 19361 | 24.21 |
03:41 ET | 30148 | 24.18 |
03:43 ET | 5543 | 24.155 |
03:45 ET | 3218 | 24.155 |
03:48 ET | 10077 | 24.17 |
03:50 ET | 5150 | 24.16 |
03:52 ET | 9139 | 24.15 |
03:54 ET | 5443 | 24.17 |
03:56 ET | 20283 | 24.19 |
03:57 ET | 20943 | 24.215 |
03:59 ET | 62519 | 24.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.1B | 32.5x | -21.77% |
PTC Therapeutics Inc | 3.0B | -5.0x | --- |
Novavax Inc | 2.2B | -4.9x | --- |
P3 Health Partners Inc | 158.7M | -0.9x | --- |
Halozyme Therapeutics Inc | 5.8B | 18.8x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.2x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.